Location History:
- Tygelsjö, SE (2015)
- Malmoe, SE (2024)
Company Filing History:
Years Active: 2015-2024
Title: Innovations by Per Einar Pontus Holm
Introduction
Per Einar Pontus Holm is a notable inventor based in Tygelsjö, Sweden. With two patented inventions to his name, he has made significant contributions to medical technology, particularly in drug delivery systems and secure communication between electronic devices.
Latest Patents
Holm's most recent patents include a drug injection device with a deflectable transducer. This invention offers an innovative design featuring a first element and a second element that can move relative to each other, thereby enhancing the functionality of drug delivery. The device is equipped with a deflectable transducer, which interacts with a series of protrusions on the first element, registering activation signals through an integrated processor.
Another key patent involves the secure pairing of electronically controlled devices. This invention describes a medical system comprising two units that communicate via distinct communication links. These links allow for the transmission of different groups of data types, enabling a more controlled sharing of information during the pairing process of the devices.
Career Highlights
Holm is affiliated with Novo Nordisk A/S, a leading global healthcare company known for its innovative solutions in diabetes care and other chronic diseases. His role at the company has positioned him at the forefront of medical device innovation, contributing to advancements that could significantly impact patient care.
Collaborations
Throughout his career, Holm has collaborated with several talented colleagues, including Henrik Bengtsson and Jens Aage Munk. These collaborations have likely enriched the development process of his inventions, bringing together diverse expertise to tackle complex challenges in medical technology.
Conclusion
In summary, Per Einar Pontus Holm stands out in the field of medical innovation with his pioneering inventions that aim to improve drug delivery systems and enhance the security of electronic communications. His work at Novo Nordisk A/S, along with his collaborations, reflects a commitment to advancing healthcare technology that could benefit countless patients.